More importantly, upregulation of PIM2 was significantly associated with shorter overall survival time (P = 0.007) (Fig. 1e) and shorter disease-free survival time (P = 0.013) of HCC patients (Fig. 1f) according to Kaplan–Meier analysis. The gene discussed is PIM2; the disease is hepatocellular carcinoma.